Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
117 FT536 Path to IND: Ubiquitous targeting of solid tumors with an off-the-shelf, first-of-kind MICA/B-specific CAR-iNK cellular immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.